Trials / Completed
CompletedNCT01093664
Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02
Phase IB Follow-up Study to Assess a Boost Immunization With AFFITOPE AD02 With Regard to Safety/Tolerability, Immunological and Clinical Activity in Alzheimer Patients Who Have Received the Vaccine Within the Clinical Study AFF002
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Affiris AG · Industry
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase IB follow-up study to assess a boost immunization with AFFITOPE AD02 with regard to safety/tolerability, immunological and clinical activity in Alzheimer patients who have received the vaccine within the clinical study AFF002.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AFFITOPE AD02 | s.c. injection |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2010-03-26
- Last updated
- 2010-10-19
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01093664. Inclusion in this directory is not an endorsement.